Top TSX Growth Companies With High Insider Ownership In September 2024

In This Article:

As the Canadian TSX navigates a seasonally volatile period, marked by softening labor markets and potential interest rate cuts, investors are seeking resilient opportunities. In this environment, growth companies with high insider ownership can offer a compelling proposition due to their alignment of interests and potential for long-term value creation.

Top 10 Growth Companies With High Insider Ownership In Canada

Name

Insider Ownership

Earnings Growth

Vox Royalty (TSX:VOXR)

12.5%

70.7%

Allied Gold (TSX:AAUC)

22.5%

73.5%

Almonty Industries (TSX:AII)

17.7%

117.6%

goeasy (TSX:GSY)

21.2%

17.1%

Alvopetro Energy (TSXV:ALV)

19.4%

72.4%

Propel Holdings (TSX:PRL)

40%

37.2%

VersaBank (TSX:VBNK)

13.3%

28.2%

Medicenna Therapeutics (TSX:MDNA)

15.4%

57.2%

Alpha Cognition (CNSX:ACOG)

17.9%

69.5%

ROK Resources (TSXV:ROK)

16.6%

161.8%

Click here to see the full list of 39 stocks from our Fast Growing TSX Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Knight Therapeutics

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products as well as medical devices worldwide with a market cap of CA$570.85 million.

Operations: The company's revenue primarily comes from its pharmaceutical segment, which generated CA$337.87 million.

Insider Ownership: 22.3%

Earnings Growth Forecast: 66.2% p.a.

Knight Therapeutics, a growth company with high insider ownership, has shown mixed financial results recently. For Q2 2024, it reported sales of C$95.57 million but a net loss of C$1.94 million compared to net income in the previous year. Despite this, its earnings are forecast to grow significantly at 66.17% per year and the company expects revenues between C$355 million and C$365 million for 2024. Knight Therapeutics has also been actively repurchasing shares under its buyback program.

TSX:GUD Earnings and Revenue Growth as at Sep 2024

Savaria

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Savaria Corporation offers accessibility solutions for the elderly and physically challenged across Canada, the United States, Europe, and internationally, with a market cap of CA$1.43 billion.

Operations: The company generates revenue primarily from Patient Care at CA$183.98 million and Segment Adjustment at CA$673.74 million.